Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer ...
Switching to a 2-drug ART regimen was highly effective and well tolerated in virologically suppressed patients with HIV.
Combination antiretroviral therapy (ART) has transformed HIV-1 infection into a chronic condition with near-normal life expectancy. For more than two decades, the standard regimen has been a ...
RICHMOND, British Columbia, March 27, 2023 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. ("bioLytical"), a global leader in rapid in-vitro medical diagnostics, announced today that it has received ...
December 3, 2010 — The US Food and Drug Administration (FDA) has approved a single-use rapid test (INSTI HIV-1; bioLytical Laboratories, Inc) that detects antibodies to HIV-1 in as little as 60 ...
RICHMOND, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- HIV testing just became faster, easier, and more accessible. The U.S. Food and Drug Administration (FDA) has approved the INSTI ® HIV Self ...
The INSTI® HIV Self Test delivers highly accurate results in 60 seconds or less, the fastest home-use HIV rapid test available. FDA-approved and ready for U.S. consumers, providing a private and ...